Trend Analysis Report On: (OTC:NVIV), (OTC:AAMRQ)
InVivo Therapeutics Holdings Corp. (OTC:NVIV) has pioneered a treatment that uses a biocompatible polymer-based scaffold to provide structural support to a damaged spinal cord in order to spare tissue from scarring while improving recovery and prognosis after traumatic SCI.
View full press release